<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="case-report" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v3i1.2213</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v3i1.2213</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary Hyperaldosteronism in a 38 Year Old Woman from Pakistan: A Case Report on Conn's Syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Sajjad Ali</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Suchal</surname>
            <given-names>Zafar Aleem</given-names>
          </name>
          <email>sufna.foundation@gmail.com</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saleem</surname>
            <given-names>Muhammad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Badini</surname>
            <given-names>Kaleemullah</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shaikh</surname>
            <given-names>Aisha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Department of Medicine, Aga Khan Medical College, AKUH, Karachi, Pakistan</institution>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Zafar Aleem Suchal (sufna.foundation@gmail.com)</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2022-03-15">
        <day>15</day>
        <month>03</month>
        <year>2022</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2022</year>
      </pub-date>
      <volume>3</volume>
      <issue>1</issue>
      <fpage>63</fpage>
      <lpage>65</lpage>
      <history>
        <date date-type="received" iso-8601-date="2021-12-21">
          <day>21</day>
          <month>12</month>
          <year>2021</year>
        </date>
        <date date-type="accepted" iso-8601-date="2021-12-26">
          <day>26</day>
          <month>12</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2022 The Author(s)</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v3i1.2213" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v3i1.2213.pdf" content-type="application/pdf"/>
      <abstract>
        <p>Conn’s syndrome refers to excess production of aldosterone by adrenal glands leading to an increase in blood pressure of the patient. There are often various other associated signs and symptoms due to which a patient may present often due to fluid overload and/or electrolyte abnormality. A 38 year old married female presented to the clinical with a raised blood pressure of 150-170 mmHg systolic and 100-120 mmHg diastolic. She also had a history of raised blood pressure during pregnancy with the first pregnancy being aborted and the second and third having markedly raised blood pressures. There was no associated history of palpitations, headache or anxiety. Her workup was done with a high aldosterone concentration and a low serum renin being detected. Her electrolytes were found to be normal and on ultrasound her kidneys were also normal. The patient was started verapamil to lower her blood pressure and a diagnoses of primary hyperaldosteronism was reached as the Plasma aldosterone to Renin ratio was raised with absence of any other cause.</p>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-keywords">
        <title>Keywords</title>
        <kwd>Hyperaldosteronism</kwd>
        <kwd>Pakistan</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <!-- <body> omitted: no manuscript (.docx) on file -->
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Lee FT, Elaraj D. Evaluation and Management of Primary Hyperaldosteronism. Surg Clinics North Am. 2019;99(4):731-45.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Kucharz EJ. Michał Lityński--a forgotten author of the first description on primary hyperaldosteronism. Pol Arch Med Wewn. 2007;117(1-2):57-8.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Stewart PM. Mineralocorticoid hypertension. Lancet. 1999;353(9161):1341-7.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Landau E, Amar L. Primary aldosteronism and pregnancy. In Annales d'endocrinologie. 2016; 77(2):148-60.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocrine reviews. 2018;39(6):1057-88.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Kronenberg H, Melmed S, Polonsky K, Larsen P.. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders; 2008</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in Ipatients with primary aldosteronism after treatment. Arch Intern Med. 2008;168(1):80-5.</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, Gabetti L, Mengozzi G, Williams TA, Rabbia F, Veglio F. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811-20.</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diab Endocrinol. 2018;6(1):51-9.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Murata M, Kitamura T, Tamada D, Mukai K, Kurebayashi S, Yamamoto T, Hashimoto K, Hayashi RD, Kouhara H, Takeiri S, Kajimoto Y. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. J Hypertens. 201;35(5):1079-85.</mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation>Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295(22):2638-45.</mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation>Salcuni AS, Palmieri S, Carnevale V, Morelli V, Battista C, Guarnieri V, Guglielmi G, Desina G, Eller‐Vainicher C, Beck‐Peccoz P, Scillitani A. Bone involvement in aldosteronism. J Bone Min Res. 2012;27(10):2217-22.</mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation>Morton A. Primary aldosteronism and pregnancy. Pregnancy Hypertension. Int J Women's Cardiovasc Health. 2015;5(4):259-62.</mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation>Corsello SM, Paragliola RM. Evaluation and Management of Endocrine Hypertension During Pregnancy. Endocrinology and metabolism clinics of North America. 2019;48(4):829-42.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
